News

Dageville disposed of 66,668 shares through a pre-established Rule 10b5-1 trading plan, retaining ~4.5 million shares worth $1.24 billion.

After a brief relief rally, stock market selling accelerated again heading into the close. The Dow Jones Industrial Average sank 1,000 points, or 1.9%. The S&P 500 fell 1%. The Nasdaq dropped 0.9%. The S&P and Nasdaq both were on pace to mark intraday comebacks but lost steam as traders digested the latest updates from Federal Reserve Chairman Kevin Warsh.

AT&T, Verizon, and T-Mobile took a beating on Wednesday as investors braced for an orbital clash with Elon Musk. Shares of AT&T (NYSE: T) and Verizon (NYSE: VZ) both fell 4%, while T-Mobile (NASDAQ: TMUS) slid 2%, following a Semafor report that SpaceX is plotting a direct assault on the U.S. wireless oligopoly. The rocket titan is actively hunting urban-grade spectrum—either by snapping up rivals or crashing next year’s federal auction—to build out dense coverage in major cities. The selloff hi

Oil stock prices should go up in response, but this time there's a catch...

Oracle's credit-default-swap cost substantially exceeds other AI-linked issuers as investors question returns from debt-funded infrastructure.

Amazon's latest borrowing attracted substantially weaker demand as technology companies issued $194 billion to finance AI investment.

Problems in Europe weighed on profits.

TSMC's U.S. shares declined as leveraged selling spread beyond Korea despite the chipmaker's record quarterly profit.

AMD secured substantial data-center capacity, but the agreement failed to insulate its shares from the global semiconductor selloff.

Tesla extended its losing streak as analysts lowered targets following weaker-than-expected second-quarter earnings.

Wall Street Selloff Deepens as Oil Soars and Fed Decision Looms

SK Hynix's earnings disappointment intensified investor scrutiny of AI spending and semiconductor growth expectations.

Elon Musk has lost $300 billion in the last six weeks.

Chip Stocks Tumble as SK hynix Miss Overshadows AI Demand Strength

Baird reduced its price target by $300 as data-center restrictions created new risks for Caterpillar's power-equipment growth.

P&G forecast weaker annual growth and maintained an estimated $1 billion profit hit from higher costs.

Shipment delays and limited shareholder-return detail overshadowed a sixfold operating-profit increase and strong AI-memory demand.

Forced selling and concerns about AI-chip expectations intensified Samsung's decline during a record-setting South Korean market rout.

A new Korean regulation could have unintended consequences for Micron investors.

AI Stock Rally Faces Reality Check as Earnings Beats Fall Flat

The market is worried that some sales challenges in the second quarter may not prove temporary.

The Dow dropped over 900 points as Iran tensions pushed oil prices sharply higher. Semiconductor stocks extended their brutal weekly decline.

Caterpillar stock sinks as Baird downgrades it to Neutral. Here’s why the firm turned bearish on CAT shares today.

Individual investors just recorded “their largest net selling of single stocks since the COVID crash,” according to Vanda Research.

Tech stocks were lower Wednesday afternoon, with the State Street Technology Select Sector SPDR ETF

The brokerage stated that growing opposition to data centre construction could weigh on demand for construction equipment and compress Caterpillar's valuation.

The telehealth provider shared patient health information with Snap and Meta, a federal complaint says.

Heavy, unusual put option volume today in Corning Inc. (GLW) shows some investors believe GLW is cheap after generating strong free cash flow. The out-of-the-money 6-month GLW short-put play is bullish.

Though positive, mid-stage study results erased about two-thirds of the biotech's market value this week. But Christopher Kroeger sees MapLight's drug as competitive based on the "totality of data."

Teva Pharmaceutical Industries climbed above an important chart level Wednesday, after the company's bullish guidance overshadowed mixed second-quarter results. Teva earnings thinned to 2 cents a share after subtracting costs from an acquisition. The profit came in below the consensus estimate of 5 cents a share.